Ewing sarcoma sample zccs227 showed differential sensitivity to a number of chemotherapeutic agents including doxorubicin, irinotecan and vincristine as well as targeted agents affecting PI3K pathway, receptor tyrosine kinase (ALK) and cell cycle (AURKA) signalling pathways (Fig. 6F). This evidence concerns the gene AURKA and Ewing sarcoma.